Search Results - "Silakari, O."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    In silico guided design of non-covalent inhibitors of DprE1: synthesis and biological evaluation by Verma, H., Choudhary, S., Kumar, M., Silakari, O.

    Published in SAR and QSAR in environmental research (03-04-2021)
    “…DprE1 is a potential target of resistant tuberculosis (TB), especially multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB. 2-benzoxazolinone is…”
    Get full text
    Journal Article
  2. 2

    Molecular dynamics and pharmacophore modelling studies of different subtype (ALK and EGFR (T790M)) inhibitors in NSCLC by Singh, P. K., Silakari, O.

    Published in SAR and QSAR in environmental research (04-03-2017)
    “…Extensively validated 3D pharmacophore models for ALK (anaplastic lymphoma kinase) and EGFR (T790M) (epithelial growth factor receptor with acquired secondary…”
    Get full text
    Journal Article
  3. 3

    In silico guided designing of 4-(1H-benzo[d]imidazol-2-yl)phenol-based mutual-prodrugs of NSAIDs: synthesis and biological evaluation by Arora, M., Choudhary, S., Silakari, O.

    Published in SAR and QSAR in environmental research (02-10-2020)
    “…The free COOH group of conventional NSAIDs is a structural feature for non-selective cyclooxygenase (COX) inhibition and the molecular cause of their…”
    Get full text
    Journal Article
  4. 4

    Energy decomposition and waterswapping analysis to investigate the SNP associated DPD mediated 5-FU resistance by Verma, H., Doshi, J., Narendra, G., Raju, B., Singh, P.K., Silakari, O.

    “…5-fluorouracil is an essential component of systemic chemotherapy for colon, breast, head, and neck cancer patients. However, tumoral overexpression of the…”
    Get full text
    Journal Article
  5. 5

    Structure based designing of benzimidazole/benzoxazole derivatives as anti-leishmanial agents by Kapil, S., Singh, P.K., Kashyap, A., Silakari, O.

    Published in SAR and QSAR in environmental research (02-12-2019)
    “…Folates are essential biomolecules required to carry out many crucial processes in leishmania parasite. Dihydrofolate reductase-thymidylate synthase (DHFR-TS)…”
    Get full text
    Journal Article
  6. 6

    Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models by Kaur, M., Silakari, O.

    Published in SAR and QSAR in environmental research (02-06-2016)
    “…Owing to the complex pathophysiology of autoimmune disorders, it is very challenging to develop successful treatment strategies. Single-target agents are not…”
    Get full text
    Journal Article
  7. 7

    Glutamine: fructose-6-phosphate amidotransferase (GFAT): homology modelling and designing of new inhibitors using pharmacophore and docking based hierarchical virtual screening protocol by Vyas, B., Silakari, O., Singh Bahia, M., Singh, B.

    Published in SAR and QSAR in environmental research (01-09-2013)
    “…Glutamine: fructose-6-phosphate amidotransferase (GFAT), also termed GFPT1 and GFAT1, catalyzes the first committed step of the hexosamine biosynthesis pathway…”
    Get full text
    Journal Article
  8. 8

    Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2 by Jasuja, H., Chadha, N., Kaur, M., Silakari, O.

    Published in SAR and QSAR in environmental research (01-01-2014)
    “…Janus kinase 1 and 2, non-receptor protein tyrosine kinases, are implicated in various cancerous diseases. Involvement of these two enzymes in the pathways…”
    Get full text
    Journal Article
  9. 9

    Imidazo[1,2-a]pyrazine inhibitors of phosphoinositide 3-kinase alpha (PI3Kα): 3D-QSAR analysis utilizing the Hybrid Monte Carlo algorithm to refine receptor-ligand complexes for molecular alignment by Chadha, N., Jasuja, H., Kaur, M., Singh Bahia, M., Silakari, O.

    Published in SAR and QSAR in environmental research (04-03-2014)
    “…Phosphoinositide 3-kinase alpha (PI3Kα) is a lipid kinase involved in several cellular functions such as cell growth, proliferation, differentiation and…”
    Get full text
    Journal Article
  10. 10

    A three-dimensional pharmacophore modelling of ITK inhibitors and virtual screening for novel inhibitors by Bagga, V., Silakari, O., Ghorela, V.S., Bahia, M.S., Rambabu, G., Sarma, J.

    Published in SAR and QSAR in environmental research (01-03-2011)
    “…Interleukin-2-inducible T-cell kinase (ITK) is a key member of the Tec family of non-receptor tyrosine kinases, and has been found to be a novel target for a…”
    Get full text
    Journal Article
  11. 11

    Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation by Kaur, Gaganpreet, Silakari, Om

    Published in Bioorganic chemistry (01-10-2018)
    “…[Display omitted] •Benzimidazole scaffold based hybrids provided multitargeting potential by influencing various inflammation-related targets such as COX-1,…”
    Get full text
    Journal Article
  12. 12